KP-1461

DRUG2 trials

Sponsors

Koronis Pharmaceuticals.

Conditions

HIV Infections

Phase 1

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

CompletedNCT00129194

Koronis Pharmaceuticals.HIV Infections

Start: 2005-08-31Target: 40Updated: 2008-01-04

Phase 2

Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

TerminatedNCT00504452

Koronis Pharmaceuticals.HIV Infections

Start: 2007-07-31End: 2009-06-30Updated: 2011-11-07